Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anticancer Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ru-catalyzed cascade reaction for anticancer indenopyrazolopyrazolones. Efficient one-pot synthesis offering cost reduction and supply chain reliability for API manufacturers.
Patent CN113980017A reveals a high-yield asymmetric hydrogenation route for tetrahydro-13-methyl berberine derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN108329256B discloses a Pd-catalyzed one-pot synthesis of polysubstituted benzo[c,d]indoles. This method offers high yield, mild conditions, and scalable production for anticancer drug intermediates.
Patent CN102659705A reveals a novel base-mediated route for 3,4-disubstituted isoxazoles, offering high yields and simplified supply chains for drug manufacturing.
Patent CN108117507B details a green visible-light method for azaspirocyclohexadienone synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and high purity.
Patent CN108997339A reveals efficient Rh-catalyzed synthesis for isoindole isoquinoline carboxylates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones using chiral phosphoric acid, offering cost-effective solutions for API manufacturing.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Patent CN115261896B reveals electrochemical synthesis for high-purity intermediates. Offers cost reduction and supply chain reliability for anticancer drug manufacturing.
Patent CN112480015B details a Pd-catalyzed carbonylation method for quinazolinones. Offers high yield, mild conditions, and scalable routes for API intermediates.
Novel Pd-catalyzed route for C-3 benzyl indolizines offers high yield and operational simplicity for reliable pharmaceutical intermediate supply chains.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Patent CN112979529A discloses a novel one-step synthesis for aromatic amine indole naphthoquinone derivatives, offering significant cost reduction in API manufacturing and simplified supply chains.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN114163436A details a Pd-catalyzed route for indolizine-diarylmethanes. Delivers high-purity API intermediates with scalable cost reduction strategies.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.